Cargando…
Novel Expanded Safe Zone for Reduction of Submental Fullness with ATX-101 Injection
ATX-101 (deoxycholic acid injection; Kybella) provides an approved nonsurgical treatment option for reduction of submental fullness caused by submental fat. Current one-size-fits-all recommendations for the use of ATX-101 limit treatment to a central area, which may not provide complete resolution o...
Autores principales: | Shridharani, Sachin M., Chandawarkar, Akash A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597763/ https://www.ncbi.nlm.nih.gov/pubmed/31764639 http://dx.doi.org/10.1097/PRS.0000000000006299 |
Ejemplares similares
-
Abstract: Novel Expanded Safe Zone System for Treatment of Submental Fullness with ATX-101 (Deoxycholic Acid)
por: Shridharani, Sachin M., et al.
Publicado: (2017) -
Abstract: Alopecia in Male Patients Treated with ATX-101 (Deoxycholic Acid) for Submental Fullness
por: Shridharani, Sachin M., et al.
Publicado: (2017) -
Best Clinical Practices with ATX-101 for Submental Fat Reduction: Patient-related Factors and Physician Considerations
por: Teller, Craig F., et al.
Publicado: (2021) -
An Assessment of the Reduction of Submental Fullness With ATX-101 (Deoxycholic Acid Injection) in the Expanded Safe Zone
por: Khan, Husnain, et al.
Publicado: (2023) -
Evaluating a Topical Adjunctive Post Submental ATX-101 (Deoxycholic Acid) Injection for Improved Recovery: A Single-Center, Double-Blind, Randomized Controlled Pilot Study
por: Shridharani, Sachin M
Publicado: (2021)